Company Filing History:
2 out of 105 
2 out of 832,843 Years Active: 2001-2006
Title: Cheri Lynn Blum: Innovator in Purine Inhibitors
Introduction
Cheri Lynn Blum is a notable inventor based in Alameda, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of purine inhibitors that target cyclin-dependent kinase 2 (CDK-2). With a total of 4 patents to his name, Blum's work has implications for treating disorders characterized by undesirable cell proliferation.
Latest Patents
Blum's latest patents include innovative compounds that inhibit CDK-2 activity. One of his notable inventions is a purine inhibitor of cyclin-dependent kinase 2 and IκB-α. The compounds described in his patents feature a specific formula where R is a lower alkyl optionally substituted with hydroxy, lower alkoxy, and halogen. These compounds are designed to be effective in treating various disorders linked to excessive cell growth.
Career Highlights
Throughout his career, Cheri Lynn Blum has worked with several organizations, including Cv Therapeutics, Inc. His expertise in the field has led to advancements in therapeutic options for patients suffering from conditions related to cell proliferation.
Collaborations
Blum has collaborated with notable professionals in his field, including Robert T. Lum and Richard L. Mackman. These partnerships have contributed to the development of his innovative compounds and have enhanced the impact of his work in the pharmaceutical industry.
Conclusion
Cheri Lynn Blum's contributions to the field of purine inhibitors and his innovative patents highlight his role as a significant inventor in the pharmaceutical industry. His work continues to pave the way for advancements in treatments for disorders associated with cell proliferation.